Helping the heart pump in early cardiogenic shock
Part of Heart & circulation clinical trials.
This study is testing a device called an intra-aortic balloon pump (a small balloon placed in your heart's main artery to help it pump) for people in the early stages of cardiogenic shock, a condition where the heart can't pump enough blood. The goal is to see if adding this supportive device early on improves outcomes for patients with heart attacks or other heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be in stage B or C cardiogenic shock (heart failure that isn't pumping enough blood).
- You must have at least one abnormal lab result, such as high lactate, reduced kidney function, liver problems, or elevated NT-pro BNP.
- You can't be on more than one medication to support your heart or blood pressure.
- You can't have certain conditions like a heart valve problem, severe leg artery disease, an aortic tear, or a recent surgery.
- summary
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a temporary heart pump (Impella) can help people with severe heart failure and cardiogenic shock (when the heart can't pump enough blood). The goal is to see if this device can reduce fluid buildup and improve blood flow, but it's for people who are very ill and need extra support.
This trial looks at how well the heart's pumping is helped by using an intra-aortic balloon pump, a device inserted to support blood flow in people with cardiogenic shock. It aims to learn more about how the device works and improve care.
This trial tests whether using a small mechanical pump inside the heart plus careful monitoring with a special catheter can help people in shock after a heart attack. It compares this approach to standard care, aiming to improve survival and recovery.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
This early study looks at how well the heart is pumping in people with cardiogenic shock, using measurements taken during a right-heart catheter (a small pressure-monitoring test). It may help doctors better assess heart function and guide next-step treatments like LVAD, heart transplant, or valve surgery.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.